Narrative updates are currently in beta.

Back to narrative

Update shared on30 Jul 2025

Fair value Decreased 65%
AnalystConsensusTarget's Fair Value
US$1.98
36.7% overvalued intrinsic discount
30 Jul
US$2.70
Loading
1Y
-87.3%
7D
-11.2%

The sharp reduction in ModivCare's analyst price target from $5.57 to $1.98 is primarily driven by weaker revenue growth forecasts and a lower future P/E multiple, reflecting deteriorating growth and valuation sentiment.


What's in the News


  • ModivCare Inc. was removed from the S&P Global BMI Index.
  • Barb Gutierrez will depart as Chief Financial Officer; the CFO role will not be replaced as the company advances cost reduction and technology-driven integration efforts.

Valuation Changes


Summary of Valuation Changes for ModivCare

  • The Consensus Analyst Price Target has significantly fallen from $5.57 to $1.98.
  • The Future P/E for ModivCare has significantly fallen from 0.81x to 0.29x.
  • The Consensus Revenue Growth forecasts for ModivCare has significantly fallen from 1.2% per annum to 0.7% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.